Lilly to boost diabetes sales force

Eli Lilly said it expects to increase its diabetes sales force by 40% in 2007. The move comes as Lilly plans launch five new insulin pen delivery products and bolster efforts behind its recently launched diabetes treatment Byetta, Lilly president John Lechleiter told investors last Thursday. Byetta’s new-prescription volume increased 30% over the last month, Lilly said. The drug also recently won approval to be marketed in Europe.
You must be a registered member of MMM to post a comment.
 

Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.